Johnson & Johnson recalls 3 million bottles of medicines, including Tylenol, Benadryl, and Motrin, because of odors traced to a chemical in pallets used to transport and store the medicines.
Bayer and Johnson & Johnson announce that they have reached a $775 million agreement to settle approximately 25,000 outstanding litigation cases, which claim that their drug Xarelto caused severe and sometimes fatal bleeding episodes. Bayer and Johnson & Johnson had successfully defended the safety of the drug in all six prior cases that went to trial.
Swiss research, published in the medical journal "The Lancet", found that paracetamol -- sold as Tylenol and as a generic, acetaminophen, in the United States -- was not effective at reducing pain or improving movement in patients with osteoarthritis of the knee or hip. The analysis examined 74 randomly-selected trials published between 1980 and 2015 with 58,556 patients who had osteoarthritis. The study did find the prescription drug diclofenac, sold in the U.S. as Cataflam or Voltaren, is the most effective NSAID available. McNeil Consumer Healthcare, the makers of Tylenol, disagree with the study's conclusions.